Doping esportivo: expectativa de benefícios, realidade de riscos e outras considerações

O esporte de alto rendimento exige dos atletas desempenho máximo e, nesse contexto, há uma busca, por parte de atletas para recursos suplementares de substâncias que promovam o aumento de um já elevado desempenho. O assunto é de grande interesse, tanto para atletas e treinadores quanto para profissionais de saúde que trabalham com atletas de alto rendimento.

Objetivo: O objetivo do presente trabalho foi destacar a importância da investigação médico-científica quanto ao uso de substâncias que contribuem para o aumento no desempenho físico na relação benefícios-riscos à saúde no âmbito do esporte e do exercício.

Conclusão: A importância da investigação médico-científica quanto ao uso de substâncias e métodos que contribuam para o aumento no desempenho físico na relação benefícios-riscos à saúde no âmbito do esporte e do exercício remonta aos primórdios da prática do exercício físico, na Idade Antiga. No dias atuais, é assunto fundamental no âmbito do esporte de alto rendimento. Questões atuais foram apresentadas e discutidas.

Referências

Holt RIG, Erotokritou-Mulligan I, Sönksen PH. The history of doping and growth hormone abuse in sport. Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society. 2009;19(4): 320–326. https://doi.org/10.1016/j.ghir.2009.04.009.

Dictionary Cambridge. Fair play. Dictionary Cambridge. https://dictionary.cambridge.org/dictionary/english-portuguese/fair-play [Accessed 10th April 2024].

Wei M, Wang J. Potential health risks of foodborne performance-enhancing drugs in competitive sports. Heliyon. 2023;9(10): e21104. https://doi.org/10.1016/j.heliyon.2023.e21104.

Lusetti M, Licata M, Silingardi E, Bonsignore A, Palmiere C. Appearance/Image- and Performance-Enhancing Drug Users: A Forensic Approach. The American Journal of Forensic Medicine and Pathology. 2018;39(4): 325. https://doi.org/10.1097/PAF.0000000000000424.

Castanho GKF, Fontes EB, Fernandes PT. O perigo da contaminação de suplementos alimentares com substâncias ilícitas para os praticantes de exercício físico e esporte. Conexões. 2014;12(1): 161–180. https://doi.org/10.20396/conex.v12i1.2186.

Kremenik MJ, Onodera S, Nagao M, Yuzuki O, Yonetani S. A Historical Timeline of Doping in the Olympics (Part 1 1896-1968). Kawasaki journal of medical welfare. 2006; https://www.semanticscholar.org/paper/A-Historical-Timeline-of-Doping-in-the-Olympics-1-Kremenik-Onodera/b5d37329984a5cd2a794c0cb53b419812c1b4640

World Anti-Doping Agency. Who We Are. World Anti Doping Agency. https://www.wada-ama.org/en/who-we-are [Accessed 11th April 2024].

Fèdèration Internationale de Mèdicine du Sport A. Statement on Doping in Sport. 1993. fims.org/files/4414/2056/2561/PS13-Statement-on-Doping-in-Sport.pdf [Accessed 10th April 2024].

Fèdèration Internationale de Mèdicine du Sport. Doping nos esportes. Revista Brasileira de Medicina do Esporte. 1998;4: 28–28. https://doi.org/10.1590/S1517-86921998000100008.

World Anti-Doping Agency. The Prohibited List. World Anti Doping Agency. https://www.wada-ama.org/en/prohibited-list [Accessed 11th April 2024].

Backhouse SH. A Behaviourally Informed Approach to Reducing the Risk of Inadvertent Anti-doping Rule Violations from Supplement Use. Sports Medicine (Auckland, N.Z.). 2023;53(Suppl 1): 67–84. https://doi.org/10.1007/s40279-023-01933-x.

De Rose EH, Feder MG, Pedroso PR, Guimarães AZ. Referred use of medication and dietary supplements in athletes selected for doping control in the South-American Games. Revista Brasileira de Medicina do Esporte. 2006;12: 239–242. https://doi.org/10.1590/S1517-86922006000500003.

Kozhuharov VR, Ivanov K, Ivanova S. Dietary Supplements as Source of Unintentional Doping. BioMed Research International. 2022;2022: 8387271. https://doi.org/10.1155/2022/8387271.

Lauritzen F, Gjelstad A. Trends in dietary supplement use among athletes selected for doping controls. Frontiers in Nutrition. 2023;10: 1143187. https://doi.org/10.3389/fnut.2023.1143187.

Segatti JCM, Oliveira DV de, Antunes MD, Leme DE da C, Jacob W. Substâncias farmacológicas e o doping esportivo. Biológicas & Saúde. 2016;6(22). https://doi.org/10.25242/886862220161049.

Bialowas D, Laskowski R, Franchini E, Kujach S. Examining the effects of pre-competition rapid weight loss on hydration status and competition performance in elite judo athletes. Scientific Reports. 2023;13(1): 14756. https://doi.org/10.1038/s41598-023-41872-1.

Heuberger JAAC, Cohen AF. Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects. Sports Medicine (Auckland, N.Z.). 2019;49(4): 525–539. https://doi.org/10.1007/s40279-018-1014-1.

World Anti-Doping Agency - WADA. International Olympic Committee. https://olympics.com/ioc/wada [Accessed 11th April 2024].

Kindermann W, Meyer T. Inhaled β2 agonists and performance in competitive athletes. British Journal of Sports Medicine. 2006;40(Suppl 1): i43–i47. https://doi.org/10.1136/bjsm.2006.027748.

Riiser A, Stensrud T, Stang J, Andersen LB. Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: a systematic review and meta-analysis of randomised controlled trials. British Journal of Sports Medicine. 2021;55(17): 975–983. https://doi.org/10.1136/bjsports-2019-100984.

Purnama SK, Doewes RI, Elumalai G, Azmi SH, Nuryadin I, Manshuralhudlori. Biosensor development in sports doping with dexamethasone. Revista Brasileira de Medicina do Esporte. 2023;29: e2022_0416. https://doi.org/10.1590/1517-8692202329012022_0416.

Dvorak J, Feddermann N, Grimm K. Glucocorticosteroids in football: use and misuse. British Journal of Sports Medicine. 2006;40(Suppl 1): i48–i54. https://doi.org/10.1136/bjsm.2006.027599.

Juszczak A, Morris D, Grossman A. Cushing’s Syndrome. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al. (eds.) Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. http://www.ncbi.nlm.nih.gov/books/NBK279088/ [Accessed 12th April 2024].

Henderson LP, Penatti C a. A, Jones BL, Yang P, Clark AS. Anabolic androgenic steroids and forebrain GABAergic transmission. Neuroscience. 2006;138(3): 793–799. https://doi.org/10.1016/j.neuroscience.2005.08.039.

Wenbo Z, Yan Z. The Uses of Anabolic Androgenic Steroids Among Athletes; Its Positive and Negative Aspects- A Literature Review. Journal of Multidisciplinary Healthcare. 2023;16: 4293–4305. https://doi.org/10.2147/JMDH.S439384.

Allen MJ, Sabir S, Sharma S. GABA Receptor. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. http://www.ncbi.nlm.nih.gov/books/NBK526124/ [Accessed 15th April 2024].

Watson CJ, Stone GL, Overbeek DL, Chiba T, Burns MM. Performance-enhancing drugs and the Olympics. Journal of Internal Medicine. 2022;291(2): 181–196. https://doi.org/10.1111/joim.13431.

Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology. 2014;32(4): 347–355. https://doi.org/10.1038/nbt.2842.

Cantelmo RA, da Silva AP, Mendes-Junior CT, Dorta DJ. Gene doping: Present and future. European Journal of Sport Science. 2020;20(8): 1093–1101. https://doi.org/10.1080/17461391.2019.1695952.

Dragčević D, Pandžić Jakšić V, Jakšić O. Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping. Arhiv Za Higijenu Rada I Toksikologiju. 2024;75(1): 24–31. https://doi.org/10.2478/aiht-2024-75-3793.

Reardon CL, Creado S. Drug abuse in athletes. Substance Abuse and Rehabilitation. 2014;5: 95–105. https://doi.org/10.2147/SAR.S53784.

Tidmas V, Halsted C, Cohen M, Bottoms L. The Participation of Trans Women in Competitive Fencing and Implications on Fairness: A Physiological Perspective Narrative Review. Sports (Basel, Switzerland). 2023;11(7): 133. https://doi.org/10.3390/sports11070133.

International Olympic Committee. Olympic Modern Pentathlon. https://olympics.com/en/paris-2024/sports/modern-pentathlon. https://olympics.com/en/paris-2024/sports/modern-pentathlon [Accessed 15th April 2024]

Acessar